Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen, 1-α-hydroxyvitamin d3 and calcium lactate on vertebral bone loss in early menopausal women

Maturitas

Volumn 28, Issue 1, 1997, Pages 11-17

  Itoi, Hideo ^a   Minakami, Hisanori ^a   Sato, Ikuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Estriol; Menopause; Osteoporosis; Quantitative computed tomography

Indexed keywords

ALFACALCIDOL; ESTRADIOL;

ADULT; ARTICLE; BONE DENSITY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ALKALINE PHOSPHATASE; BONE DENSITY; CALCIUM; ESTRIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYDROXYCHOLECALCIFEROLS; HYDROXYPROLINE; LACTATES; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED; OSTEOCALCIN; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0030707861     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(97)00061-3     Document Type: Article

References (30)

1. Barzel US. Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review. Am J Med 1988;85:847-50.
2. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319-24.
3. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. J Am Med Assoc 1996;275:370-5.
4. Hahn RG. Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet Gynecol 1989;161:1854-8.
5. Doren M, Reuther G, Minne HW, Schneider HPG. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol 1995;173: 1446-51.
6. Tzingounis VA, Aksu MF, Greenblatt RB. Estriol in the management of the menopause. J Am Med Assoc 1978;239:1638-41.
7. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753-6.
8. Heuser HP, Staemmler HJ. Histological investigations into the effect of oestriol succinate on the corpus uteri in postmenopausal women. Arzneim Forsch 1973;23:558-62.
9. 3 in peri-and postmenopausal women: effects of bone loss and lipoprotein lipids. Chin Med J 1992;105:929-933 (in English).
10. Melis GB, Cagnacci A, Bruni V, et al. Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause. Maturitas 1996;24:83-90.
11. Minaguchi H, Uemura T, Shirasu K, et al. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study. J Obstet Gynaecol Res 1996;22:259-65.
12. Nozaki M, Hashimoto K, Inoue Y, Sano M, Nakano H. Usefulness of estriol for the treatment of bone loss in postmenopausal women. Nippon Sanka Fujinka Gakkai Zasshi 1996;48:83-8.
13. Nishibe A, Morimoto S, Hirota K, et al. Effect of estriol and bone mineral density of lumbar vertebrae in elderly and postmenopausal women. Nippon Ronen Igakkai Zasshi 1996;33:353-9.
14. Pacifici R, Susman N, Carr PL, Birge SJ, Avioli LV. Single and dual energy tomographic analysis of spinal trabecular bone: a comparative study in normal and osteoporotic women. J Clin Endocrinol Metab 1987;64:209-14.
15. Genant HK, Ettinger B, Cann CE, Reiser U, Gordan GS, Kolb FO. Osteoporosis: assessment by quantitative computed tomography. Orthop Clin North Am 1985;16:557-68.
16. Genant HK, Cann CE, Ettinger B, Gordan GS. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982;97:699-705.
17. Pacifici R, Rupich R, Griffin M, Chines A, Susman N, Avioli LV. Dual energy radiography versus quantitative computed tomography for the diagnosis of osteoporosis. J Clin Endocrinol Metab 1990;70:705-10.
18. Elders PJM, Netelenbos JC, Lips P, et al. Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 1991;73:533-40.
19. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993;328:460-4.
20. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994;54:370-6.
21. 3) and calcium in osteoporosis. Clin Orthop Relat Res 1994;300:241-7.
22. Bergman I, Loxley R. The determination of hydroxyproline in urine hydrolysates. Clin Chim Acta 1970;27:347-52.
23. Genant HK, Faulkner KG, Gluer CC. Measurement of bone mineral density: current status. Am J Med 1991;91(Suppl 5B):49s-53s.
24. Heaney RP, Recker RR, Saville PD. Menopausal changes in bone remodeling. J Lab Clin Med 1978;92:964-70.
25. Johansen JS, Riis BJ, Delmas PD, Christiansen C. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988;18:191-5.
26. Riis BJ, Johansen JS, Christiansen C. Continuous oestrogen-progestogen treatment and bone metabolism in postmenopausal women. Maturitas 1988;10:51-8.
27. Riis BJ. Biochemical markers of bone turnover in diagnosis and assessment of therapy. Am J Med 1991;91(Suppl 5B):64s-8s.
28. Stepan JJ, Pospichal J, Presl J, Pacovsky V. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. Bone 1987;8:279-84.
29. Nielsen HK, Brixen K, Bouillon R, Mosekilde L. Changes in biochemical markers of osteoblastic activity during the menstrual cycle. J Clin Endocrinol Metab 1990;70:1431-7.
30. Chen TL, Aronow L, Feldman D. Glucocorticoid receptors and inhibition of bone cell growth in primary culture. Endocrinology 1977;100:619-28.